Biomed Diagnostics, Inc. changed the world of in-vitro prepared media culture testing when it pioneered and patented InPouch® and InTray®. Products which dramatically reduce lab costs by simplifying culture diagnostics while increasing accuracy.
For over 30 years, Biomed Diagnostic’s innovative culture diagnostics devices have been trusted by clinicians and laboratory professionals in over 60 countries. Their company took shape over three decades ago when a group of physicians doing aid work in the remote areas of Costa Rica discovered the need for robust diagnostic tools which could be readily available and combine multiple diagnostic steps in exposed, austere environments. Today, they continue to partner with researchers, hospitals, humanitarian organizations, and laboratories the world over to design and develop prepared media in their unique devices. Every high-quality product is developed to comply with regulatory requirements, regardless of industry or field.
Specializing in the development of automated clinical instrumentation for the testing of Bacterial Culture in Urine and Biological Liquids.
Incorporated in 1988 as a privately owned company, Alifax® specializes in the development, production and distribution of automated clinical diagnostic instrumentation for the determination of Bacterial Culture in Urine and Human Biological Liquids. Recognizing the need for innovation in the diagnostic Health Care System, Alifax is strongly focused on scientific research and technology development. Alifax has obtained worldwide patents in bacteriology and continue to collaborate with experts in the field of microbiology to publish more than 100 national and international scientific papers.
Meridian Bioscience Inc.
Meridian Bioscience is a fully integrated life science company that manufactures and markets a broad range of innovative diagnostic test kits. Their products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. Meridian diagnostic products require little or no special equipment.
Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. For example, The CDC’s new guidelines recommend that laboratories perform Shiga toxin testing on all stools submitted for enteric pathogen testing. Meridian has always been a leader in the field of E. coli testing. Meridian was the first to provide an EIA microwell to detect Shiga toxin produced by E. coli (Premier™ EHEC), and Meridian has raised the bar again with the introduction of the rapid ImmunoCard STAT!® EHEC.